Precision medicine & chronic diseases
Chronic diseases, such as heart disease, stroke, cancer and diabetes account for 70% of all deaths globally.
Our world-leading researchers are at the forefront of developing new treatments and diagnostics for chronic diseases, and informing policies and practices to improve individual and population health and reduce inequalities.
It is currently estimated that only 25%-50% of prescribed medicines work for the patients they are prescribed to. Precision or Stratified medicine is an innovative new approach which subdivides patients into groups based on their likely response to particular therapies. By using advanced diagnostic tests precision medicine can precisely select the best treatment for patients thereby dramatically improving outcomes.
The University’s Clinical Innovation Zone at the Queen Elizabeth University Hospital (QEUH) campus is now Scotland’s focal point for the implementation of precision medicine, with the Stratified Medicine Scotland Innovation Centre (SMS-IC) located there.
This world-class facility combined with the The Institute of Health and Wellbeing and a potential Alliance for Chronic Diseases on the new Western site will allow Glasgow to tackle the rising tide of chronic diseases through basic and clinical research, and at the same time improve prevention of medical conditions through public intervention.
With your support we can improve global health.
